AXIM Assays Headed Into 40 Clinics
DIAGNOSTICS: Business Targets Dry Eye Disease, Brings COO on Board
■ By BRAD GRAVES
Dry Eye Disease, also known as DED, is a condition that can be difficult to diagnose. Mira Mesa-based AXIM Biotechnologies (OTBQB: AXIM) is working to put it in a better light.
Late last month (May 24), AXIM announced the launch of its diagnostic...
Read latest San Diego Business Journal online.